$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/133
  • C07D-217/00
출원번호 UP-0636903 (2006-12-11)
등록번호 US-7727997 (2010-06-22)
발명자 / 주소
  • John, Varghese
  • Maillard, Michel
  • Jagodzinska, Barbara
  • Beck, James
  • Gailunas, Andrea
  • Freskos, John
  • Mickelson, John
  • Samala, Lakshman
  • Sealey, Jennifer
  • Tenbrink, Ruth
  • Fang, Larry
  • Hom, Roy
출원인 / 주소
  • Elan Pharmaceuticals, Inc.
대리인 / 주소
    McDonnell Boehnen Hulbert & Berghoff LLP
인용정보 피인용 횟수 : 17  인용 특허 : 19

초록

Disclosed are compounds of the formula wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of disorders such as Alzheimer's Disease.

대표청구항

What is claimed is: 1. A compound of the formula or a pharmaceutically acceptable salt thereof, wherein R30 is selected from the group consisting of pyrazolopyrimidinyl, isoxazolyl, triazolopyridinyl, pyridyl, furyl, naphthothienyl, thiadiazolyl, oxazolidinyl, pyrazinyl mono N-oxide, benzofuran

이 특허에 인용된 특허 (19)

  1. Chrysler Susanna M. S. ; Sinha Sukanto ; Keim Pamela S. ; Anderson John P., .beta.-secretase.
  2. Hardy John Anthony ; Chartier-Harlin Marie-Christine,FRX ; Goate Alison Mary ; Owen Michael John,GB6 ; Mullan Michael John, APP770 mutant in alzheimer's disease.
  3. Gordon Eric M. (Palo Alto CA) Barrish Joel C. (Holland PA) Bisacchi Gregory S. (Lawrenceville NJ) Sun Chong-Qing (East Windsor NJ) Tino Joseph A. (Lawrenceville NJ) Vite Gregory D. (Trenton NJ) Zahle, Aminediol protease inhibitors.
  4. Seubert Peter A. ; Schenk Dale B. ; Fritz Lawrence C., Antibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of .beta.APP.
  5. Anderson John P. ; Jacobson-Croak Kirsten L. ; Sinha Sukanto, Assays for detecting .beta.-secretase.
  6. Schenk Dale B. (Pacifica CA) Seubert Peter A. (South San Francisco CA) Vigo-Pelfrey Carmen (Mountain View CA), Methods for the detection of soluble b 상세보기
  • McConlogue Lisa C. (San Francisco CA) Schenk Dale B. (Pacifica CA) Seubert Peter A. (South San Francisco CA) Sinha Sukanto (San Francisco CA) Zhao Jun (La Jolla CA), Methods of screening for b 상세보기
  • Schlossmacher Michael G.,ATX ; Selkoe Dennis J., Methods of screening for compounds which inhibit soluble .beta.-amyloid peptide production.
  • Coles Richard J. (Uxbridge GB2), N-Cyclopropylisoindolines.
  • Liversidge Gary G. ; Engers David A. ; Roberts Mary E. ; Ruddy Stephen B. ; Wong Sui-Ming ; Xu Shuqian, Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers.
  • Eppstein Deborah A. (Los Altos CA) Fraser-Smith Elizabeth B. (Los Altos CA) Matthews Thomas R. (Los Gatos CA), Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides.
  • Liversidge Gary G. (West Chester PA) Cundy Kenneth C. (Pottstown PA) Bishop John F. (Rochester NY) Czekai David A. (Honeoye Falls NY), Surface modified drug nanoparticles.
  • McConlogue Lisa C. (San Francisco CA) Zhao Jun (San Diego CA), Transgenic animals harboring APP allele having swedish mutation.
  • Cordell Barbara (Palo Alto CA), Transgenic mice displaying the amyloid-forming pathology of alzheimer\s disease.
  • Hsiao Karen ; Borchelt David R. ; Sisodia Sangram S., Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease.
  • Wadsworth Samuel ; Snyder Benjamin ; Wei Cha-Mer ; Leibowitz Paul J., Transgenic mouse assay for compounds affecting amyloid protein processing.
  • Wadsworth Samuel ; Snyder Benjamin ; Wei Cha-Mer ; Leibowitz Paul J., Transgenic mouse expressing APP.sub.770.
  • Cordell Barbara, Transgenic non-human mice displaying the amyloid-forming pathology of alzheimer's disease.
  • McLonlogue Lisa C. ; Zhao Jun, Transgenic rodents harboring APP allele having swedish mutation.
  • 이 특허를 인용한 특허 (17)

    1. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John, PRMT5 inhibitors and uses thereof.
    2. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John, PRMT5 inhibitors and uses thereof.
    3. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John, PRMT5 inhibitors and uses thereof.
    4. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    5. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    6. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    7. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    8. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    9. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    10. Duncan, Kenneth W.; Chesworth, Richard; Munchhof, Michael John, PRMT5 inhibitors and uses thereof.
    11. Duncan, Kenneth W.; Chesworth, Richard; Munchhof, Michael John, PRMT5 inhibitors and uses thereof.
    12. Duncan, Kenneth W.; Chesworth, Richard; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    13. Duncan, Kenneth W.; Chesworth, Richard; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    14. Duncan, Kenneth W.; Chesworth, Richard; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    15. Duncan, Kenneth W.; Chesworth, Richard; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors and uses thereof.
    16. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John; Jin, Lei, PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof.
    17. Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann; Munchhof, Michael John; Jin, Lei, Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof.

    문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로